The roll out of the program began in 2004, according to the post, with one of it’s first initiatives being to revise the antibiotic restriction policy.
Since then, the team has created 17 specific clinical pathways for conditions such as
– Skin/Soft tissue infections
– Urinary Tract Infections
– Acute Bacterial Meningitis
– Pelvic Inflammatory Disease.
All of these pathways are available to BMC staff on the Internet and the hospital’s EHR.
With guidelines, pathways and policies set, what is next for the team?
Patient-level recommendations and employing a prospective audit and feedback method.
Chief Pharmacy Officer at BMC, David Twitchell, noted on the program’s future.
“At first, the antimicrobial stewardship program was largely retrospective, big-picture review of past usage and misadventures, trying to education people to do better in the future…Today, we’re targeting areas of misuse, and reports issued each morning enable Dana and Kelly to immediately intervene.”
Dana Whitney and Kelly Wright are on the program’s core team.
To read more about BMC and its program, click here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
